Microbiology and Rare infectious diseases | Conference Series | International Scientific and Medical Conferences

Quick Links

World Congress on Microbiology and Rare infectious diseases

Theme: Novel Advancements and Therapeutic Acuities in Clinical Microbiology & Infectious Diseases

MICROBE INFECTIONS 2021

MICROBE INFECTIONS 2021

Conference series invites all participants from around the world to attend the “World Congress on Microbiology and Rare Infectious Diseases” (MICROBE INFECTIONS 2021) from June 25-26, 2021, which includes quick introductory presentations, oral lectures, poster presentations and exhibitions.

The aim of our conference is to provide an opportunity to share knowledge, expertise as well as unprecedented networking opportunities among a large number of medical and industrial professionals in this field. The lecture series brings together physicians, pharmacists, scientists, microbiologists, young researchers, health industry delegates and communities of talented students in the medical sciences under one roof where networking and partnerships global events are happening to accelerate future research.

About MICROBE INFECTIONS 2021

Conference Series, through its Open Access initiative, is committed to making authentic and trusted contributions to the scientific community. Conference series LLC hosts over 700 leading open access peer-reviewed journals and has hosted over 3,000 scientific conferences around the world.

The lecture series welcomes all physicians, pharmacists, scientists, microbiologists, young researchers, industrial health delegates and talented student communities in the field of the microbiology department to attend this World Congress on Microbiology and Rare Infectious Diseases, where all aspects of applied microbiology and all infections related to microbes will be discussed under one roof. Microbe Infections 2021 will be a great fusion of academia and industry, as it involves all aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies, both academic and industrial.

Why to Attend MICROBE INFECTIONS 2021?

Microbes Infection 2021 Highlights Theme 'Discovering New Challenges in Microbiology & infectious diseases' With members from around the world focused on learning about microbiology and rare infectious diseases and its breakthroughs in industry innovation pharmaceutical, food, brewing, clinical health systems, hospitals and research organizations. This is the best opportunity to reach the largest assemblage of participants from the microbiology community, host presentations, disseminate information, meet current and potential scientists, make a splash with new medical techniques in recent trends and receive name recognition during this 2-day event. World-renowned speakers, scientists, doctors, the latest innovations, developments and latest updates of MICROBE INFECTIONS 2021 are important for this conference.

Pathologist of Infectious Diseases
Irresistible Diseases Specialists
Human services Professionals
Professors
Pediatricians
Microbiologists
Scientists
Restorative Students
Delegates from Pharmacists organizations
Chiefs/Co-Directors of Research based organizations over the globe.

Track 1: Microbiology

Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi, and protozoa. This discipline includes basic research on the biochemistry, physiology, cell biology, ecology, evolution and clinical forms of microorganisms, including the host response to these agents. The researcher in microbiology is appointed microbiologist. Microbiologists study microbes (including bacteria, archaea, viruses, fungi, prions, protozoa, and algae). Some microbes play a key role in nutrient cycling and in the production of beneficial products. humans such as drugs, antibiotics, vaccines and biotechnology engineered products.

ASIA-PACIFIC:

Pan-Pacific Surgical Association Congress, Federation of Asia-Pacific Microbiology Societies, Malaysian Society of Infectious Diseases, Singapore Society for Microbiology and Biotechnology, Malaysian Society for Microbiology, Asia Pacific Society of Clinical Microbiology and Infection, The Philippine Society for Microbiology, Asia Pacific Society for Marine Biotechnology, Committee of Asia Pacific Electron Microscopy Societies, Federation of Asia Pacific Microbiological Societies, International Union of Microbiological Societies; Singapore National Academy of Sciences, Japanese Society of Microbial Ecology

USA:

Federation of American societies for experimental biology, American society for microbiology, Society for industrial Microbiology and biotechnology, Society for Applied Microbiology, Society for industrial microbiology, International Union of microbiological societies, Southern California Branch of the American Society for Microbiology, Southeastern association for clinical microbiology, Association of medical school microbiology and immunology chairs.

EUROPE:

Italian Society of Agro-Food and Microbial Biotechnologies, Federation of European Microbiological Societies, European Molecular Biology Organization, Society for Applied Microbiology, Swiss Society for Infectious Disease, European Molecular Biology Organization, International Center for Genetic Engineering and Biotechnology, Federation of European Microbiological Societies, European Society for Clinical Virology, International Union of Microbiological Societies.

Track 2: Microbes

In microbiology, we study the microscopic organism or a single celled organism such as Bacteria, viruses, fungi and others which are called microbes. These microbes play key roles in nutrient cycling, biodegradation / biodeterioration, climate change, food spoilage, disease cause and control, and biotechnology. Thanks to their versatility, microbes can be used in a number of ways: manufacturing life-saving medicines, manufacturing biofuels, pollution control, and food and beverage production / processing.

There are also infectious agents of different shapes and sizes. Bacteria and protozoa are microscopic, single-celled organisms, while viruses are even smaller. Fungi grow like plants, and helminths look like worms.

ASIA-PACIFIC:

USA:

EUROPE:

Track 3: Infectious Diseases Research

Infectious diseases - also known as contagious diseases, communicable diseases, or communicable diseases - are caused by pathogenic microorganisms that infect a host organism and can spread, directly or indirectly, from one organism to another.

Infectious disease research has the potential for wide application because everyone, in all parts of the world, is infected with microbes at some point in their life.

Microbes are simple organisms capable of rapid genetic mutation. Many are moving to new strains that are resistant to available therapies. The ease of international travel and a growing world population facilitate the problems associated with rapid microbial evolution.

ASIA-PACIFIC:

USA:

EUROPE:

Track 4: Infectious Microbes and Diseases

Microbes that cause disease are called pathogens. A pathogen is a microorganism that has the potential to cause disease. An infection is the invasion and multiplication of pathogenic microbes in an individual or a population. Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi or parasites.Illness occurs when infection causes damage to an individual's functions or vital systems. Pathogens cause disease by disrupting normal body processes and / or stimulating the immune system to produce a defensive response, resulting in high fever, inflammation? and other symptoms.

ASIA-PACIFIC:

USA:

EUROPE:

Track 5: Viral infection diseases

Viruses are very small germs. They are made up of genetic material inside a protein coating. Viruses cause familiar infectious diseases such as the common cold, the flu, and warts. They also cause serious illnesses such as HIV / AIDS, smallpox and Ebola.

Viruses are like hijackers. They invade living, normal cells and use these cells to multiply and produce other viruses like them. It can kill, damage or change cells and make you sick. Different viruses attack certain cells in your body such as your liver, respiratory system or blood.A viral disease is an illness or medical condition caused by a virus. Read on to learn more about some of the main types of viral illnesses:Not all viral diseases are contagious. This means that they don't always spread from person to person. But many of them are. Common examples of contagious viral illnesses include the flu, colds, HIV, and herpes.

The current epidemic of viral infectious diseases is coronavirus disease (COVID-19) Coronaviruses are zoonotic, which means they are transmitted between animals and humans. Detailed investigations revealed that SARS-CoV was transmitted from civets to humans and MERS-CoV from dromedaries to humans. Several known coronaviruses are circulating in animals that have not yet infected humans.

ASIA-PACIFIC:

USA:

EUROPE:

Track 6: Bacterial infection diseases

A bacterial infection is an overgrowth of a harmful strain of bacteria on or inside the body. Bacteria can infect any area of the body. Pneumonia, meningitis, and food poisoning are just a few of the illnesses that can be caused by harmful bacteria. Bacteria come in three basic forms: rod-shaped (bacilli), spherical (cocci) or helical (spirilla). Bacteria can also be classified as gram-positive or gram-negative. Gram-positive bacteria have a thick cell wall, unlike Gram-negative bacteria. Gram stain, bacterial culture with antibiotic sensitivity determination, and other tests are used to identify bacterial strains and help determine the appropriate treatment.

ASIA-PACIFIC:

USA:

EUROPE:

Track 7: Fungal infection

Fungal infections are common in natural world. In humans, fungal infections occur when an invading fungus invades an area of the body and is too large for the immune system to handle. Fungi can live in air, soil, water, and plants. There are also fungi that naturally live in the human body.Like many microbes, there are useful fungi and harmful fungi. When harmful fungi invade the body, they can be difficult to kill because they can survive in the environment and re-infect the person trying to heal.Fungal infections are silent killers and cause misery for millions of people. More die from fungal diseases than from tuberculosis or malaria. After headaches and rotten teeth, skin yeast infections are the most common illnesses on Earth. Serious fungal infections affect the most economically productive, especially in patients with tuberculosis, AIDS and cancer, having a disproportionate impact on economies.

Common symptoms of fungal infections are:

skin changes, including red and possibly cracked or peeling skin, itch

ASIA-PACIFIC:

USA:

EUROPE:

Track 8: Parasitic infection diseases

Parasites are living things that use other living things - like your body - for food and life. You can get them from contaminated food or water, from an insect bite, or from sexual contact. Some parasitic diseases are easy to treat and some are not.Parasites vary in size from tiny, single-celled organisms called protozoa to worms visible to the naked eye. Some parasitic diseases occur in the United States. Contaminated water supplies can lead to Giardia infections. Cats can transmit toxoplasmosis, which is dangerous for pregnant women. Others, like malaria, are common in other parts of the world.Among the hundreds of known parasite species, only small fractions are capable of causing disease in humans. Among them are the protozoa Entamoeba histolytica, which causes amoebic dysentery and is acquired by ingestion of food or water contaminated with the feces of a human carrier of the infectious organism, and the flagellated protozoa Trypanosoma brucei gambiense and T. brucei rhodesiense, which causes sleeping sickness (African trypanosomiasis) and is transmitted to humans through the bite of infected tsetse flies.

ASIA-PACIFIC:

USA:

EUROPE:

Track 9: Microbiology research advancement

Deadly bacteria linked to butterfly color changes,Like many poisonous animals, the orange, white, and black pattern of the African monarch butterfly warns predators that it is poisonous. Warning patterns like this are generally consistent between individuals to help predators learn to avoid them. However, a recent study shows how a population of African monarch butterflies (Danaus chrysippus) breaks this rule and exhibits widely varying warning patterns.

ASIA-PACIFIC:

USA:

EUROPE:

Track 10: Antimicrobial Resistance

Antimicrobial resistance occurs when microorganisms (such as bacteria, fungi, viruses, and parasites) change when exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals, antimalarials and anthelmintics). Microorganisms that develop resistance to antimicrobials are sometimes called “superbugs”.New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases, leading to prolonged illness, disability and death.Without effective antimicrobials for the prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, management of diabetes, and major surgeries (for example, cesarean sections or hip replacements) become very risky.Antimicrobial resistance increases the cost of healthcare with longer hospital stays and more intensive care needed.

Antimicrobial resistance jeopardizes the achievements of the Millennium Development Goals and endangers the achievement of the Sustainable Development Goals.Antimicrobial resistance occurs naturally over time, usually through genetic changes. However, the misuse and overuse of antimicrobials accelerates this process. In many places, antibiotics are overused and misused in humans and animals, and often administered without professional supervision. Examples of misuse include when taken by people with viral infections such as colds and flu, and when administered as growth promoters in animals or used to prevent disease in healthy animals. health.

ASIA-PACIFIC:

USA:

EUROPE:

Track 11: Microbiology and Infectious diseases

Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi, and protozoa. It includes basic research on the biochemistry, physiology, cell biology, ecology, evolution and clinical aspects of microorganisms, including the host response to agents. Infectious diseases are diseases caused by organisms such as bacteria, viruses, fungi or parasites. Some infectious diseases can be transmitted from person to person while some are transmitted by insects or other animals. Each infectious disease has its own specific signs and symptoms. Most infectious diseases have only minor complications, while some infections like pneumonia, AIDS and meningitis can be life threatening.

ASIA-PACIFIC:

USA:

EUROPE:

Track 12: Bacterial and Fungal Infectious Diseases

A bacterial infection is an overgrowth of a harmful strain of bacteria on or inside the body. Bacteria can infect any area of the human body. Pneumonia and food poisoning are just some of the illnesses that can be caused by harmful bacteria. Bacteria come in three basic forms: rod-shaped, spherical, or helical. Bacteria are also classified as gram-positive or gram-negative. Fungal infections represent the invasion of tissues by one or more species of fungi and range from localized superficial skin conditions to deeper tissue infections, including serious pulmonary, blood or systemic diseases. Types of fungi include molds, yeasts, and fungi. Fungi can cause different types of illnesses, including:Asthma or allergies,Rashes or infections on the skin and nails,Lung infections with symptoms similar to flu or tuberculosis,Blood infections,Meningitis.

ASIA-PACIFIC:

USA:

EUROPE:

Track 13: Industrial Microbiology

Industrial microbiology is a branch of applied microbiology in which microorganisms are used in industrial processes and these microorganisms are particularly important for synthesizing a number of products valuable to human beings and have profoundly changed our lives and our lifetimes. These products include beverages, food additives, animal health products and biofuels. There are different ways of manipulating a microorganism in order to increase the yields of the product. Introduction of mutations into an organism can be accomplished by introducing them to mutagens. Another way to increase production is through gene amplification, which is done using plasmids and vectors. Advances in industrial microbiology have made it possible to isolate enzymes in commercial quantities.

ASIA-PACIFIC:

USA:

EUROPE:

Track 14: Food Microbiology

Food microbiology includes the study of microorganisms that cause food spoilage; as well as pathogens that can cause disease, especially if food is undercooked or stored. It includes microorganisms which have both beneficial and harmful effects on the quality and safety of food and therefore may be of concern to public health. Careful preparation of food, including proper cooking, eliminates most bacteria and viruses found in food. However, toxins produced by contaminants may not be likely to turn into non-toxic forms when heating or cooking contaminated food. Temperature plays a very crucial role in controlling microbial growth. To ensure the safety of food products, certain microbiological tests such as tests for pathogens and spoilage organisms are necessary. In this way, the risk of contamination under normal conditions of use can be examined and food poisoning can be avoided.

ASIA-PACIFIC:

USA:

EUROPE:

Track 15: Animal and Environmental Microbiology

Environmental microbiology is the study of microbes in all habitats and their beneficial and harmful effects on human health and well-being. It also includes the study of microorganisms that exist in artificial environments such as bioreactors. The microbial world is very diverse and a large number of microorganisms cover the planet. Veterinary microbiology concerns the etiology, pathogenesis, laboratory diagnosis and treatment of infection in the individual and epizootiology (the study of mass diseases in animals) and the prevention and control of infection in the community.

ASIA-PACIFIC:

USA:

EUROPE:

Industry Insights:

The global infectious diseases in vitro diagnostics market size was valued at USD 16.3 billion in 2019 and is projected to register a CAGR of 6.2% from 2019 to 2027. Increase in external funds for Research and Development (R&D) purposes and favorable government initiatives are some of the key growth drivers of the market for IVD infectious diseases.

Rapid rise of the global geriatric population is one of the key drivers for market growth as aging is directly proportional to several chronic diseases. According to the United Nations’ World Population Aging Report 2019, the number of elderly people aged 80 years and above-currently estimated at 143 million in 2019-is projected to triple by 2050 and would reach 426 million.

Increasing burden of target diseases, rising health awareness, and shift toward self-care clinical devices are projected to drive the market for IVD infectious diseases. Moreover, advancements in IVD kits with improved speed, sensitivity, and patient compliance is anticipated to increase the penetration of IVD kits for diagnosing infectious diseases.

Technological progress has led to the introduction of advanced IVD tools, such as mobile Real Time Polymerase Chain Reaction (qPCR), in the market for IVD infectious diseases. The dynamics of the market drive the adoption of technologies, most prominently self-testing tools for infectious diseases. However, expenses associated with IVD diagnostic tests and lack of stringent regulatory framework are inhibiting market growth.

Report Coverage & Deliverables:

PDF report & online dashboard will help you understand:

Competitive benchmarking
Market forecasts
Company market shares
Market opportunities
Latest trends & dynamics

Product Insights:

Reagents dominated the product segment in 2019. Rise in the number of R&D initiatives associated with molecular diagnostic tools and increasing demand for self-test and point of care products are expected to maintain the market position of this segment through the forecast period. The segment is estimated to exhibit a CAGR of 6.5% over the forecast period.

Analytical instruments include machines and equipment that enable process automation as well as combine samples and reagents. Commercialized IVD kits assist in disease diagnosis using PCR for detection and quantification of infectious microorganisms, viral load, and blood antigens.

Application Insights:

IVD find wide-spread application in the diagnosis and testing of multiple infectious diseases such as Methicillin-resistant Staphylococcus aureus (MRSA), HIV, streptococcal infections, hepatitis, and influenza. HIV tests accounted for the largest share of the infectious diseases in vitro diagnostics market in 2019. This is attributed to the rapidly escalating disease burden and high unmet medical needs in emerging economies.

Tuberculosis (TB) and drug-resistant TB are expected to demonstrate steady growth over the next few years. It is estimated that HIV-infected people are 26 to 31 times more likely to suffer from TB due to a compromised immune system. Furthermore, key diagnostic manufacturers are constantly updating the range of diagnostic tests, particularly IVD kits, for their instruments through several R&D initiatives and investments in clinical trials. This leads to the development of affordable and efficient diagnostic kits to address the burden of infectious diseases.

End-use Insights:

Central laboratories emerged as the largest end-use segment in 2019, driven primarily by the large volume of tests carried out in central laboratories. The point of care (PoC) segment is anticipated to exhibit the highest CAGR over the forecast period owing to increasing initiatives intended to reduce hospital stays to limit healthcare expenditure and growing need for rapid diagnosis for detecting infectious diseases.

Increasing patient demand for bedside care, supported by rising adoption of decentralized healthcare establishments and flourishing home healthcare sector, is also driving the market growth. Moreover, increasing adoption of self-care or OTC diagnostics in developing markets such as China and India, growing consumer awareness, and advancements in healthcare infrastructure are driving the demand for IVD kits for the detection of infectious diseases.

Technology Insights:

Based on technology, immunochemistry generated the highest revenue in 2019, followed closely by molecular diagnostics. However, molecular diagnostics is estimated to be the largest segment by 2027 owing to the increasing penetration and growing demand for sensitive, accurate, and rapid new-age devices such as advanced IVD kits for diagnosing infectious diseases. Moreover, microbiology is expected to demonstrate moderate growth, supported by new-age molecular diagnostic techniques replacing traditional methods.

Molecular diagnostics renders accurate and fast results in the IVD field, thus playing an imperative role in the diagnosis and treatment of infectious diseases. Moreover, rising burden of hospital-acquired infections is expected to drive the demand for molecular IVD kits. Furthermore, growing burden of sexually transmitted diseases, especially HPV and HIV, is likely to increase the target patient base, subsequently driving the demand for IVD tools for detecting infectious diseases.

Regional Insights:

North America accounted for a share of a little over 44.0% of the global market in 2019, and this trend is expected to continue through the forecast period. This is attributed to high awareness levels of practitioners and patients, proactive government initiatives, and presence of sophisticated healthcare infrastructure.

Asia Pacific is expected to register the highest CAGR from 2019 to 2027, fueled by the presence of favorable government initiatives for infectious disease testing, high unmet medical needs, economic development and consequent rise in disposable income, and increase in healthcare spending in emerging countries such as China, India, and South Korea.

Infectious Diseases In Vitro Diagnostics Market Share Insights:

Key players in the market include bioMérieux SA; BD; Abbott; Alere Inc.; Quidel Corporation; F. Hoffmann-La Roche Ltd.; Orasure Technologies, Inc.; Cepheid; Hologic Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; and Siemens Healthcare GmbH.

Increasing instances of strategic collaborations, aimed at enhancement of R&D for improved therapeutics, has created abundant growth opportunities in the market. Technological progress in diagnostic platforms is likely to introduce advanced and upgraded versions of IVD tools for the advanced treatment of infectious diseases.

Report Scope:

Attribute	Details
Base year for estimation	2019
Actual estimates/Historical data	2015 - 2018
Forecast period	2020 - 2027
Market representation	Revenue in USD Million and CAGR from 2019 to 2027
Regional scope	North America, Europe, Latin America, Asia Pacific, Middle East & Africa
Country scope	U.S., Canada, Germany, U.K., Spain, France, Italy, Brazil, Mexico, Argentina, Japan, China, India, South Korea, Australia, South Africa, Saudi Arabia, UAE
Report coverage	Revenue forecast, competitive landscape, growth factors, and trends
15% free customization scope (equivalent to 5 analysts working days)	If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2015 to 2027. For the purpose of this study, Grand View Research has segmented the global infectious diseases in vitro diagnostics market report on the basis of product, technology, application, end use, and region:

Product Outlook (Revenue, USD Million, 2015 - 2027)
- Instruments
- Reagents
- Software
Technology Outlook (Revenue, USD Million, 2015 - 2027)
Immunochemistry
Molecular Diagnostics
Microbiology
Others
MRSA
Streptococcus
Clostridium difficile
VRE
CRE
Respiratory Virus
Candida
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
Chlamydia
Gonorrhea
HPV
HIV
Hepatitis C
Hepatitis B
Others
Point of Care
Central Laboratories
North America
- U.S.
- Canada
Europe
U.K.
Germany
Spain
France
Italy
Brazil
Mexico
Argentina
Japan
China
India
South Korea
Australia
South Africa
Saudi Arabia
UAE
Latin America
Asia Pacific
Middle East & Africa
Application Outlook (Revenue, USD Million, 2015 - 2027)
End-use Outlook (Revenue, USD Million, 2015 - 2027)
Regional Outlook (Revenue, USD Million, 2015 - 2027)

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 25-26, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

World Congress on Microbiology and Rare infectious diseases June 25-26, 2021 Osaka, Japan

Recommended Global Microbiology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

MICROBE INFECTIONS 2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues